39,301 Shares in Envision Healthcare Co. (EVHC) Acquired by Russell Investments Group Ltd.
Russell Investments Group Ltd. acquired a new position in Envision Healthcare Co. (NYSE:EVHC) during the fourth quarter, Holdings Channel reports. The fund acquired 39,301 shares of the company’s stock, valued at approximately $2,527,000.
Other hedge funds also recently bought and sold shares of the company. Seven Bridges Advisors LLC acquired a new stake in Envision Healthcare during the third quarter valued at approximately $119,000. First New York Securities LLC NY acquired a new stake in Envision Healthcare during the third quarter valued at approximately $134,000. Pacer Advisors Inc. boosted its stake in Envision Healthcare by 7.4% in the third quarter. Pacer Advisors Inc. now owns 7,045 shares of the company’s stock valued at $157,000 after buying an additional 484 shares during the period. Laurion Capital Management LP acquired a new stake in Envision Healthcare during the third quarter valued at approximately $223,000. Finally, Howard Hughes Medical Institute boosted its stake in Envision Healthcare by 47.4% in the third quarter. Howard Hughes Medical Institute now owns 11,420 shares of the company’s stock valued at $254,000 after buying an additional 3,672 shares during the period. Hedge funds and other institutional investors own 35.96% of the company’s stock.
Shares of Envision Healthcare Co. (NYSE:EVHC) opened at 63.16 on Tuesday. The stock’s 50 day moving average price is $68.22 and its 200-day moving average price is $45.67. The stock’s market cap is $7.34 billion. Envision Healthcare Co. has a one year low of $57.32 and a one year high of $83.27.
Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, February 28th. The company reported $1.15 EPS for the quarter, missing the consensus estimate of $1.24 by $0.09. Envision Healthcare had a net margin of 6.06% and a return on equity of 8.05%. The company had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the prior year, the company earned $1.07 earnings per share. The company’s revenue for the quarter was up 97.4% on a year-over-year basis. On average, equities analysts predict that Envision Healthcare Co. will post $1.40 earnings per share for the current fiscal year.
Your IP Address:
Several analysts have commented on the company. Cantor Fitzgerald restated an “overweight” rating on shares of Envision Healthcare in a report on Thursday, March 16th. TheStreet cut Envision Healthcare from a “b-” rating to a “c+” rating in a report on Thursday, March 9th. Zacks Investment Research cut Envision Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, March 7th. Royal Bank of Canada restated an “outperform” rating and issued a $80.00 price target (down previously from $87.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. Finally, Jefferies Group LLC restated a “buy” rating and issued a $82.00 price target (down previously from $90.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. One research analyst has rated the stock with a sell rating, three have given a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Envision Healthcare currently has a consensus rating of “Buy” and a consensus price target of $55.80.
In other news, insider Robert Jon Coward sold 1,500 shares of the company’s stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $65.00, for a total transaction of $97,500.00. Following the completion of the sale, the insider now directly owns 104,319 shares of the company’s stock, valued at $6,780,735. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.